Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
316
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

807
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
807

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Low Post-Treatment Recurrence After a Shortened All-oral Regimen for Pulmonary Rifampicin- or Multidrug-Resistant Tuberculosis in Individuals without Prior Second-Line Drug Exposure in Kazakhstan.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Silicosis prevalence and associated occupational risk factors among cassiterite (tin ore) miners in eastern Rwanda: a cross-sectional analysis of mining practice and risk in an active mining cohort.

Occupational and environmental medicine·2026
Same author

Extensively Drug-Resistant Tuberculosis with Conflicting Resistance Testing Results, Lesotho.

Emerging infectious diseases·2025
Same author

Evaluating the impact of the COVID-19 pandemic on viral load and CD4 monitoring for people living with HIV on ART in rural Lesotho.

BMC infectious diseases·2025
Same author

Racial and Sociodemographic Disparities in Hepatitis C Treatment at an Urban Academic Medical Center, 2018-2023.

Open forum infectious diseases·2025
Same author

Design, implementation and outcomes of a national oxygen distribution network in Lesotho.

BMJ global health·2025

相关实验视频

Updated: Jun 14, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K

结核病后的肺病:解决政策差距

Chase Yarbrough1,2,3,4, Michael Miller1,4, Mosala Zulu3

  • 1Harvard Medical School, Boston, Massachusetts, United States of America.

PLOS global public health
|September 5, 2024
PubMed
概括

结核病后肺部疾病 (PTLD) 影响了结核病治疗后超过一半的患者,导致慢性损伤. 目前的结核病政策忽视了PTLD,需要综合诊断和护理策略.

更多相关视频

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

18.9K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

198

相关实验视频

Last Updated: Jun 14, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
10:04

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

18.8K
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

18.9K
A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
03:47

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients

Published on: October 25, 2024

198

科学领域:

  • 公共卫生 公共卫生
  • 呼吸系统医学 呼吸系统医学
  • 传染性疾病 传染性疾病

背景情况:

  • 结核病 (TB) 治疗可以治愈感染,但往往会导致长期功能障碍.
  • 结核病后肺部疾病 (PTLD) 影响了超过50%的完成结核病治疗的患者,这代表了全球健康负担.
  • 在目前的国际和国家结核病政策和指导方针中,PTLD在很大程度上没有得到解决,尽管其患病率和发病率很高.

研究的目的:

  • 突出PTLD作为结核病的长期并发症的重大负担.
  • 倡导将PTLD纳入全球结核病政策和临床指南.
  • 强调需要在PTLD诊断和管理方面制定标准.

主要方法:

  • 审查当前的结核病治疗结果和患者发病率.
  • 分析现有的国际和国家结核病政策和指导方针.
  • 评估目前对结核病后慢性呼吸系统障碍的治疗方法.

主要成果:

  • 在完成结核病治疗的患者中,超过一半的患者会发展为PTLD,这是慢性呼吸系统功能障碍的主要原因.
  • 在主要的结核病政策讨论和临床管理指南中,PTLD显然缺席.
  • 缺乏用于PTLD诊断和护理的确立的临床标准.

结论:

  • 迫切需要明确的临床标准来诊断和管理PTLD.
  • 所有完成结核病治疗的患者都应进行PTLD查.
  • 将PTLD整合到慢性护理中,包括获得吸入器和家庭氧气,至关重要. 像全球基金这样的资助者应该在他们的战略和资金中优先考虑PTLD.